Argentus Capital Management’s West Pharmaceutical WST Stock Holding History

Argentus Capital Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-3,870	Closed	-$264K	–	674
2016 Q1	$264K	Sell	3,870 -739	-16%	-$44.5K	0.09%	263
2015 Q4	$278K	Sell	4,609 -12,731	-73%	-$766K	0.09%	217
2015 Q3	$938K	Sell	17,340 -2,972	-15%	-$173K	0.14%	178
2015 Q2	$1.18M	Sell	20,312 -295	-1%	-$16.5K	0.18%	159
2015 Q1	$1.24M	Buy	20,607 +7,221	+54%	+$385K	0.2%	155
2014 Q4	$713K	Buy	+13,386	New	+$670K	0.12%	225

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Argentus Capital Management's WST Position: Q2 2016 in Review

Argentus Capital Management sold out of West Pharmaceutical (WST) in Q2 2016, closing a stake of 3,870 shares — an estimated $264K sold.

Argentus Capital Management first reported a position in WST in Q4 2014 and held it in 6 quarters. The position peaked at $1.24M in Q1 2015. 289 funds tracked by Wall St. Rank hold WST as of Q2 2016.

Argentus Capital Management reported no remaining West Pharmaceutical position as of Q2 2016 after selling out during the quarter.
Argentus Capital Management sold 3,870 West Pharmaceutical shares in Q2 2016, an estimated $264K.
Argentus Capital Management first reported a position in West Pharmaceutical in Q4 2014 and held it in 6 quarters.
Argentus Capital Management's West Pharmaceutical position peaked at $1.24M in Q1 2015.
289 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2016.

Based on Argentus Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.